Webinar Series on Blood Disorders
CDC’s Division of Blood Disorders (DBD) is proud to offer its “Webinar Series on Bleeding and Clotting Disorders.” The purpose of this series is to provide evidence-based information on new research, interventions, emerging issues of interest in blood disorders, as well as innovative approaches in collaborations and partnerships. We invite you to join us in this series.
Webinar Coming Soon
Prevention and Treatment of Venous Thromboembolism During Pregnancy
Andra H. James, MD, MPH, Consulting Professor of Obstetrics and Gynecology at Duke University
When: October 13, 2015, 2:00 – 3:00 pm EST
October 13 marks World Thrombosis Day—a day to focus attention on the often overlooked and misunderstood disease of thrombosis. The International Society on Thrombosis and Haemostasis (ISTH) is proud to collaborate with the Centers for Disease Control and Prevention (CDC) in supporting World Thrombosis Day and the efforts to place a global spotlight on thrombosis as an urgent and growing public health problem. In honor of World Thrombosis Day, ISTH and CDC are co-hosting a special webinar on venous thromboembolism (VTE) and pregnancy. Pregnant women are especially at increased risk for thrombosis, particularly venous thromboembolism (VTE). Women who have a history of thrombosis or inherited or acquired risk factors for VTE (also known as thrombophilias) may be much more likely to develop VTE when pregnant. Additionally, pregnant women who are hospitalized or have surgery are at increased risk for developing healthcare-associated VTE (HA-VTE). In this webinar, Dr. James will discuss the key issues concerning the occurrence of VTE during pregnancy and the postpartum period.
- Describe the epidemiology of pregnancy-related thrombosis.
- Describe the underlying biologic changes and causes of pregnancy-related VTE.
- List the risk factors for VTE at the time of childbirth and in the postpartum period.
- List the strategies for managing and preventing VTE at the time of childbirth and during the months after delivery.
- Describe an appropriate risk assessment of VTE for pregnant women.
- Describe how to talk with patients about their risks for HA-VTE.
This webinar is free and open to public health professionals, clinicians, and researchers who desire more information about VTE and pregnancy. Please register here.
Archives for 2015
March 19, 2015
Greg Maynard, MD, MSc, SFHM
"Preventing Hospital-Associated Venous Thromboembolism: Practical Strategies that Work". In this presentation, Dr. Maynard discussed key issues and opportunities for reducing hospital-associated venous thromboembolism.
January 22, 2015
Andra H. James, MD
"Reproductive Issues in Women with Bleeding Disorders" Andra H. James, MD In this webinar, Dr. James discussed key issues for women of reproductive age who have bleeding disorders.
Archives for 2014
November 6, 2014
"Venous Thromboembolism: Recent Advances in Reducing the Disease Burden"
Gary E. Raskob, PhD, MSc
In this webinar, Dr. Raskob reviewed the disease burden from venous thromboembolism. He also discussed strategies to reduce this burden through the prevention of first time and recurrent blood clots.
July 10, 2014
"Vitamin K and Vitamin K Deficiency Bleeding in Infants"
Lauren Marcewicz, MD
In this presentation, Dr. Marcewicz reviewed how vitamin K works in infants, discussed the different classifications of vitamin K deficiency bleeding, and explained how to talk with parents about the administration of this important public health measure. To access the slides from this presentation, please click here.
July 24, 2014
"Inhibitor Testing: State of the Art"
Connie Miller, PhD
In this presentation, Dr. Miller described the development of inhibitors in people who have hemophilia. She described different methods available for inhibitor testing and discussed the CDC laboratory's role in national inhibitor monitoring.
April 3, 2014
"New Challenges in Hemophilia”
Guy Young, MD
Director, Hemostasis and Thrombosis Center at Children’s Hospital Los Angeles
Associate Professor of Pediatrics at the University of Southern California Keck School of Medicine
In this presentation, Dr. Young described many new changes that are coming to the field of hemophilia during the next few years, including new treatment strategies, new issues concerning bone health, and impacts of overweight and obesity. Dr. Young also addressed specific challenges for people with hemophilia who have an inhibitor.
March 6, 2014
"Understanding Deep Vein Thrombosis: What Everyone Needs to Know”
Beth Waldron, MA
Program Director, Clot Connect
University of North Carolina at Chapel Hill
In this presentation, Beth Waldron presented the risk factors, symptoms, treatment, prevention strategies, and her personal experience with deep vein thromboembolism and pulmonary embolism.
February 6, 2014
"Venous Thromboembolism and Cancer”
Alok Khorana, MD
Director of the Gastrointestinal Malignancies Program at Taussig Cancer Institute of the Cleveland Clinic.
In this presentation, Dr. Khorana detailed the prevalence, consequences, and costs of venous thromboembolism (VTE) and described the importance of both predicting and preventing VTE in people who have cancer.
- Page last reviewed: September 15, 2015
- Page last updated: September 15, 2015
- Content source: